QURE UNIQURE NV US FDA Inspections 8-K Filing 2024 - FDA Designation uniQure N.V. announced that the U.S. FDA has granted orphan drug designation to its gene therapy AMT-191 for treating Fabry disease.Get access to all SEC 8-K filings of the UNIQURE NV